The Harvard Drug Group recalls Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: T…

Recall date

February 23, 2023

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0432-2023

FDA classification

Class II

Brand / firm

The Harvard Drug Group

Sold / distributed

Distributed Nationwide in the USA

Why it was recalled

Packaging defect: observed packaging defect, blister packaging inadequately sealed.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4